Favorable radiological outcome of skeletal Erdheim-Chester disease involvement with anakinra

Joint Bone Spine

Volumn 80, Issue 2, 2013, Pages 206-207

  Aubert, Olivier ^a   Aouba, Achille ^a   Deshayes, Soizic ^b   Georgin Lavialle, Sophie ^a   Rieu, Philippe ^c   Hermine, Olivier ^a  

^a CNRS   (France)

^b INSTITUT JEAN GODINOT   (France)

^c REIMS UNIVERSITY HOSPITAL   (France)

Author keywords

Anakinra; Erdheim Chester disease; IL 1 receptor antagonist

Indexed keywords

C REACTIVE PROTEIN; CORTISONE; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; RETINOIC ACID;

ADULT; ARTICLE; BONE PAIN; CASE REPORT; COMPUTER ASSISTED EMISSION TOMOGRAPHY; ERDHEIM CHESTER DISEASE; FEMALE; FEVER; FOLLOW UP; HUMAN; HYDRONEPHROSIS; LOW BACK PAIN; RETROPERITONEAL FIBROSIS; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE; URETER STENT;

ADULT; ANTIRHEUMATIC AGENTS; ERDHEIM-CHESTER DISEASE; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; POSITRON-EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY; TREATMENT OUTCOME;

EID: 84875521991     PISSN: 1297319X     EISSN: 17787254     Source Type: Journal    
DOI: 10.1016/j.jbspin.2012.07.005     Document Type: Article

References (10)

1. Boissel N., Wechter B., Leblond V. Treatment of refractory Erdheim-Chester disease with double autologous hematopoietic stem-cell transplantation. Ann Intern Med 2001, 135:844-845.
2. Sheidow T.G., Nicolle D.A., Heathcote J.G. Erdheim-Chester disease: two cases of orbital involvement. Eye (Lond) 2000, 14:606-612.
3. Aouba A., Georgin-Lavialle S., Pagnoux C., et al. Rational and efficacy of interleukin-1 targeting in Erdheim-Chester disease. Blood 2010, 116:4062-4070.
4. Tran T.A., Pariente D., Lecron J.C., et al. Arthritis Rheum 2011, 63:403.
5. Hauschild A., Dummer R., Ugurel S., et al. Combined treatment with pegylated interfero-alpha-2a and dacarbazine in patients with advanced metastatic melanoma: a phase 2 study. Cancer 2008, 113:1404-1411.
6. Hervier B., Arnaud L., Charlotte F., et al. Treatment of Erdheim-Chester disease with long-term high-dose interferon-α. Semin Arthritis Rheum 2012, 41:907-913.
7. Braiteh F., Boxrud C., Esmaeli B., et al. Successful treatment of Ersheim-Chester disease, a non-Langerhans-cell histocytosis, with interferon-alpha. Blood 2005, 106:2992-2994.
8. Arnaud L., Malek Z., Archambaud F., et al. 18F-Fluorodeoxyglucose-Positron Emission tomography scanning is more useful in followup than in the initial assessment of patients with Erdheim-Chester disease. Arthritis Rheum 2009, 60:3128-3138.
9. Janku F., Amin H.M., Yang D., et al. Response of histiocytoses to imatinib mesylate: fire to ashes. J Clin Oncol 2010, 28:e633-e636.
10. Balink H., Hemmelder M.H., de Graaf W., et al. Scintigraphic diagnosis of Erdheim-Chester disease. J CLin Oncol 2011, 29:e470-e472.